Latest filing published 29 Sept 2017 for Advanced Proteome Therapeutics Corporation, €41k.
Randal Chase appears in our data through filings on Advanced Proteome Therapeutics Corporation shares, published by SEDI. In total, 5 filings cover trades dated from 2 June 2015 to 28 September 2017.
Purchases make up the whole of the open-market record (1 purchase, €1,420). Buying on the open market means paying the going price with one's own funds, a different act from receiving shares as pay. Outside the open market, there are 1 option exercise. Since January 2017: 1 purchase and no sales on the market.
The latest filing, published on 29 September 2017, reports a transaction of €41k in Advanced Proteome Therapeutics Corporation. The last insider purchase was made public on 9 February 2017, 3,547 days ago. Filings reach the SEDI feed a median of 2 days after the trade. That lag is the time during which only the insider knows about the trade. Every figure here comes from the filings published by SEDI and describes the past, not future prices; it is not investment advice.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
5 of 5 declarations